DEA’s rescheduling of hydrocodone tied to declines in prescribing
DEA's rescheduling of hydrocodone tied to decreases in prescribingSecret clinical point: The DEA's reclassifying of hydrocodone analgesics from schedule III to the more limiting schedule II produced an abrupt and significant decline in prescriptions. Major finding: There were 26.3 million less prescriptions for hydrocodone ...See all stories on this subject http://www.youtube.com/watch?v= Dancing for happiness [...]